Navigation Links
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Date:7/16/2008

tudies has been locked.

About VIAject(TM)

VIAject(TM) is an ultra rapid-acting injectable human insulin intended for meal-time use by patients with Type 1 or Type 2 diabetes. In Phase I and Phase II clinical trials, VIAject(TM) has been shown to have a more rapid onset of activity than those reported for the existing rapid-acting insulin analogs. As a result, VIAject(TM) may be safer, require a lower dose and promote weight loss when compared to currently marketed meal-time insulins. VIAject(TM) has been tested in two pivotal Phase III clinical trials, which compared the effects of VIAject(TM) to Humulin(R) R, the leading recombinant human insulin.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed by using VIAdel(TM) technology, which reformulates existing FDA-approved peptide drugs. The Company's lead product candidate, VIAject(TM), is an ultra rapid-acting injectable meal-time insulin in development for use by patients with Type 1 or Type 2 diabetes. VIAject(TM) has been tested in two pivotal Phase III clinical trials. Biodel's pipeline also includes VIAtab(TM) a sublingual tablet formulation of insulin in the Phase I stage of clinical testing, and two pre-clinical osteoporosis product candidates. For further information regarding Biodel, please visit the Company's website at http://www.biodel.com.

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, including statements regarding our strategy, future operations, future clinical trial results, future financial position, future revenues, projected costs, prospects, plans and objectives
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
4. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
5. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
8. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
9. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
10. Sosei Announces Completion of Phase III Trial for NorLevo(R)
11. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015 Zimmer Holdings, Inc. (NYSE and ... that its Board of Directors has approved the payment of ... of 2015. The cash dividend of $0.22 per ... to stockholders of record as of the close of business ... to approval of the Board of Directors and may be ...
(Date:5/5/2015)... 5, 2015  Trovagene, Inc. (NASDAQ:  TROV), a ... financial results for the three months ended March ... quarter, we presented favorable clinical results at ASCO ... demonstrating our Precision Cancer Monitoring platform,s ability to ... and lung cancers," said Antonius Schuh, Ph.D., chief ...
(Date:5/5/2015)...  IBM Watson Health (NYSE: IBM ) today announced ... Mayo Clinic to advance patient health by applying the ... As Watson,s capabilities are applied to EHRs, ... of the medical factors that could impact an individual,s health ... customers – some of the largest and most-recognized healthcare ...
Breaking Medicine Technology:Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 2IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 3IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 4
... Deb Group today announced the availability of ... first group monitoring system to report hand hygiene ... hospitals can now immediately monitor compliance rates based ... for Hand Hygiene." A stand-alone system, the DebMed®GMS™ ...
... LONG BRANCH, N.J., March 1, 2011 Pharma ChemOutsourcing today ... member companies of the USA,s various state biotechnology associations to ... would like to attend the September 12-15 show in New ... of hundreds of successful biotechnology companies over the past 12 ...
Cached Medicine Technology:Deb Group Introduces First Real-time Hand Hygiene Group Monitoring System Based on World Health Organization Guidelines 2Deb Group Introduces First Real-time Hand Hygiene Group Monitoring System Based on World Health Organization Guidelines 3Pharma ChemOutsourcing Targets BioNJ, PA Bio, MassBio, BayBio, SoCalBio, and NY Biotechnology Association Member Companies for September 2011 Show in New Jersey 2
(Date:5/5/2015)... (PRWEB) May 05, 2015 Skedans ... of Victoria BC announced the Skedans Sensor Collaboration Platform ... for mobile and web app developers, provides tooling to ... and mobile sensors. , The Skedans Sensor Collaboration Platform ... intersection of the Internet of Things, Web Real Time ...
(Date:5/5/2015)... Austin, TX (PRWEB) May 05, 2015 ... aftercare programs and revenue cycle management for addiction treatment ... company as Vice President of Business Development. Mr. Mooney, ... the addiction treatment field, will be responsible for developing ... market distribution of MAP’s core products and new initiatives. ...
(Date:5/5/2015)... Grand Bahama (PRWEB) May 05, 2015 ... its Orthopedic Lifestyle Report today. The study was conducted ... conditions such as osteoarthritis and sports-related injuries ... pain and stiffness was the most prevalent symptom reported ... functionality such as walking, standing and bending over. Over ...
(Date:5/5/2015)... On April 8th, 2015, at the famous Avalon ... Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, a daylong event organized ... placement in TV and film. , A gathering ... sound and socially conscious products and services, the EcoLuxe ... appearances at various awards ceremonies and festivals each year, ...
(Date:5/5/2015)... Don’t have time to go to the gym? ... know which workout equipment to use? LiveStreamingFitness.com now ... members achieve their heath and fitness goals and live ... wellness company, today announces the launch of LiveStreamingFitness.com, a ... certified trainers, nutritional information and recipes provided by an ...
Breaking Medicine News(10 mins):Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3
... said Wednesday it had tied up with private healthcare ... 100 cities. // , ,Under the agreement, Apollo ... WebWorld cyber stores in 105 cities to offer high-quality ... to the Apollo Telemedicine Networking Foundation (ATNF), said a ...
... of Michigan Kellogg Eye Center had developed a rapid ... ,Scientists have created a first-of-its-kind test on a // ... for patients with the blinding disease known as retinitis ... reliable and cost-effective., ,In the new issue of ...
... had been linked to health hazards before but a ... deaths caused by air pollution. The study shows that ... times greater than earlier believed., ,The study appears ... researchers of the University of Southern California, among the ...
... always been stated time and again that smoking is injurious ... respiratory system. The effects of smoking may be understood by ... // lungs., ,Monoamine oxidase A (MAOA) is important in ... blood pressure. In a new study, researchers at the National ...
... of elderly people may be a long way off, but ... and slow the crippling illness, say experts.//, ,"Not many ... process of ageing with phases of forgetfulness and slowing down ... slowly goes blank," N.M. Narula, president of the Delhi chapter ...
... cancer is the most common cancer affecting men and occurs ... Men above the age of 50 years should undergo the ... // Prostate Specific Antigen, by monitoring the levels of PSA ... of the disease should begin regular prostate screening exams at ...
Cached Medicine News:Health News:Active Lifestyle Helps To Slowdown Illness In Alzheimer's Patients 2
Lederer periosteal elevators....
Miller Collburn periosteal elevators....
Langebeck periosteal elevators....
Modified Freer periosteal elevator, #163, slight curve, 21 cm....
Medicine Products: